Pacific Biosciences
PACB
#6557
Rank
HK$5.61 B
Marketcap
HK$18.61
Share price
-5.16%
Change (1 day)
20.75%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2025 (TTM): HK$1.20 Billion

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is HK$1.20 Billion. In 2024 the company made a revenue of HK$1.19 Billion a decrease over the revenue in the year 2023 that were of HK$1.56 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$1.20 B0.77%
2024 HK$1.19 B-23.65%
2023 HK$1.56 B56.22%
2022 HK$1.00 B-1.49%
2021 HK$1.01 B66.4%
2020 HK$0.61 B-13.6%
2019 HK$0.70 B14.97%
2018 HK$0.61 B-15.69%
2017 HK$0.73 B3.81%
2016 HK$0.70 B-2.18%
2015 HK$0.71 B53.01%
2014 HK$0.46 B115.08%
2013 HK$0.21 B8.5%
2012 HK$0.20 B-23.43%
2011 HK$0.26 B1918.9%
2010 HK$13.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
HK$33.38 B 2,673.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
HK$1.26 B 5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$342.11 B 28,329.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$340.45 B 28,192.06%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$26.13 B 2,071.93%๐Ÿ‡บ๐Ÿ‡ธ USA